Anti-emetic control with ondansetron in the chemotherapy of …

Emerging


7
Citations
0
Refs
1991
Year
Search Works
Work Details
  • PMID https://pubmed.ncbi.nlm.nih.gov/1831629
  • OpenAlex ID W2417483213
  • Type Article
  • Language EN
  • Published 01 Jan 1991
  • Volume 27 Suppl 1
  • Pages S15–7; discussion S22
  • Source PubMed
  • Publisher National Institutes of Health
  • FWCI 0.97
  • Countries 1
  • Institutions 1
  • Added 24 Jun 2016
  • Updated 27 Oct 2026
MENU
0

Anti-emetic control with ondansetron in the chemotherapy of breast cancer: a review.

Article 1991 EN

Nausea and vomiting are significant problems in patients receiving outpatient chemotherapy for breast cancer. Three, randomised, double-blind studies comparing the efficacy and safety of ondansetron with placebo in patients receiving 14-day CMF (Study 1), and with metoclopramide in patients receiving FAC/FEC (Study 2) or EC (Study 3) are reviewed. Ondansetron was superior to placebo in Study 1; co…

7

Citations

0

References

1

Authors

0.97

FWCI

Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
1 authors
#AuthorInstitutionsORCID
1 Norbert Walter Marschner Corresponding Universitätsmedizin Göttingen (DE)

Data: OpenAlex